Blackstone Life Sciences announces $455M collaboration with Boston Scientific on VITALYST program

Blackstone Life Sciences announced a $455 million collaboration with Boston Scientific to co-fund the development of the VITALYST temporary percutaneous transvalvular circulatory support system program.

Detected & updated continuously · Source: Nebula